Product Introduction: TELMISTRONG 40

TELMISTRONG 40 is a widely prescribed angiotensin II receptor blocker manufactured by Alkem. Composed of 40mg of Telmisartan, this tablet is indicated for the treatment of essential hypertension and reduction of cardiovascular morbidity in high-risk patients. By relaxing blood vessels, it lowers systemic blood pressure and improves cardiovascular efficiency.

Primary Indications

• Treatment of essential hypertension (high blood pressure).
• Reduction of cardiovascular morbidity in patients with established cardiovascular disease.
• Management of hypertension in patients with Type 2 Diabetes and nephropathy.

Therapeutic Benefits

• Consistent BP Control: Long-acting formulation provides smooth 24-hour blood pressure control with a single daily dose.
• Cardioprotection: Lowers the risk of stroke, heart attack, and cardiovascular death in high-risk patients.
• Kidney Protection: Slows the progression of renal disease in diabetic hypertensive patients.

Possible Side Effects

Common side effects may include:

• Dizziness, fatigue, headache, or orthostatic hypotension.
• Mild respiratory tract infections or sinusitis.
• Mild digestive symptoms or hyperkalemia.

How to Take TELMISTRONG 40

• Take one tablet daily, with or without food, at the same time each day.
• Swallow the tablet whole with a glass of water.
• Do not stop taking the drug without consulting your doctor.

Mechanism of Action

TELMISTRONG 40 contains Telmisartan, which is a selective, non-peptide angiotensin II receptor blocker (ARB). It displaces angiotensin II with high affinity from its binding site at the AT1 receptor subtype, which is responsible for the known actions of angiotensin II. Blocking this receptor results in vasodilation and decreased aldosterone release.

Safety Warnings

• Pregnancy & Nursing: Strictly contraindicated. Avoid use if pregnant or planning to become pregnant.
• Liver Health: Since Telmisartan is extensively cleared by bile, use with caution in hepatic impairment.
• Kidney Health: Monitor renal function regularly, especially in patients with renal artery stenosis.

Patient Advice

• Avoid sudden changes in posture to prevent orthostatic dizziness.
• Monitor your blood pressure regularly and keep a record.
• Maintain a low-sodium diet and a healthy lifestyle.

Fact Box

Drug Interactions

• Lithium: May increase serum lithium concentrations and toxicity.
• NSAIDs (Ibuprofen): May reduce the blood-pressure-lowering effect.
• Potassium-Sparing Diuretics: May cause severe hyperkalemia.

User Feedback

• Patients report highly satisfactory blood pressure control, with minimal side effects.
• Highly recommended by clinicians as a reliable first-line antihypertensive therapy.